Bruker Corporation (BRKR)

NASDAQ
Currency in USD
37.62
-1.46(-3.74%)
Closed·
After Hours
37.50-0.12(-0.32%)
·
BRKR Scorecard
Full Analysis
Net income is expected to grow this year
BRKR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
37.5839.03
52 wk Range
34.1072.94
Key Statistics
Edit
Prev. Close
39.08
Open
38.46
Day's Range
37.58-39.03
52 wk Range
34.1-72.94
Volume
2.16M
Average Volume (3m)
2.36M
1-Year Change
-39.44%
Book Value / Share
11.98
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BRKR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
55.97
Upside
+48.79%
Members' Sentiments
Bearish
Bullish
ProTips
12 analysts have revised their earnings downwards for the upcoming period

Bruker Corporation News & Analysis

Show more

Bruker Corporation Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.

Bruker Corporation Earnings Call Summary for Q1/2025

  • Bruker Q1 2025 EPS of $0.47 beat $0.42 forecast; revenue of $801.4M exceeded $764.72M estimate; stock fell 2.15% pre-market
  • Revenue grew 11% YoY to $801.4M; EPS declined from $0.53 in Q1 2024; non-GAAP operating margin at 12.7%; organic revenue growth 2.9%
  • Full-year 2025 revenue guidance maintained at $3.48B-$3.55B; non-GAAP EPS expected $2.40-$2.48; potential upside in H2 2025
  • Academic government market challenges persist; expected 20-25% decline in 2025; uncertain stimulus funding in China and other regions
  • CEO noted new headwinds from policy changes and tariffs; CFO expressed confidence in portfolio transformation for above-market growth
Last Updated: 2025-05-07, 10:40 a/m
Read Full Transcript

Compare BRKR to Peers and Sector

Metrics to compare
BRKR
Peers
Sector
Relationship
P/E Ratio
72.1x−3.1x−0.5x
PEG Ratio
−0.900.110.00
Price/Book
3.2x0.8x2.6x
Price / LTM Sales
1.7x3.6x3.1x
Upside (Analyst Target)
56.7%50.0%48.6%
Fair Value Upside
Unlock27.8%8.9%Unlock

Analyst Ratings

7 Buy
7 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 55.97
(+48.79% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.53%
Dividend Yield
0.52%
Industry Median 0.75%
Annualized payout
0.20
Paid quarterly
5-Years Growth
+4.56%
Growth Streak

Earnings

Latest Release
May 07, 2025
EPS / Forecast
0.47 / 0.42
Revenue / Forecast
801.40M / 764.72M
EPS Revisions
Last 90 days

BRKR Income Statement

People Also Watch

21.99
COLB
-2.66%
549.44
CHE
-0.53%
130.02
KRYS
-2.27%
97.51
AMED
+0.17%

FAQ

What Is the Bruker (BRKR) Stock Price Today?

The Bruker stock price today is 37.62

What Stock Exchange Does Bruker Trade On?

Bruker is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Bruker?

The stock symbol for Bruker is "BRKR."

Does Bruker Pay Dividends? What’s The Current Dividend Yield?

The Bruker dividend yield is 0.51%.

What Is the Bruker Market Cap?

As of today, Bruker market cap is 5.72B.

What Is Bruker's Earnings Per Share (TTM)?

The Bruker EPS (TTM) is 0.53.

When Is the Next Bruker Earnings Date?

Bruker will release its next earnings report on Jul 30, 2025.

From a Technical Analysis Perspective, Is BRKR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Bruker Stock Split?

Bruker has split 0 times.

How Many Employees Does Bruker Have?

Bruker has 11396 employees.

What is the current trading status of Bruker (BRKR)?

As of Jun 18, 2025, Bruker (BRKR) is trading at a price of 37.62, with a previous close of 39.08. The stock has fluctuated within a day range of 37.58 to 39.03, while its 52-week range spans from 34.10 to 72.94.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.